ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Beyond Febrile Neutropenia: Risks Associated with Antibiotic Choice in Children with Leukemia that Undergo Transplant||Children's Hospital of Philadelphia / Caitlin Elgarten, MD||Young Investigator Grants||2018||Pennsylvania|
|Functional Characterization of RELA Fusion Ependymoma as a Basis for Therapeutic Targeting||St. Jude Children's Research Hospital / Stephen Mack, PhD||'A' Award Grants||2018||Tennessee|
|Describing the Biological Impacts of Gain-of-function SAMD9 Mutations||Vanderbilt University Medical Center / Jason Schwartz, MD/PhD||Young Investigator Grants||2018||Tennessee|
|Effect of SLCO Polymorphisms on High-Dose Methotrexate Clearance in Pediatric Oncology Patients||Vanderbilt University Medical Center / Rachael Schulte, MD||Young Investigator Grants||2018||Tennessee|
|NUDT15 Polymorphisms and Individualization of Thiopurine Therapy in Children with Acute Lymphoblastic Leukemia||St. Jude Children's Research Hospital / Takaya Moriyama, MD/PhD||Young Investigator Grants||2018||Tennessee|
|Interrogation of Neuroblastoma Dependencies and RNAs on the Core-Regulatory Circuitry for Therapeutic Inhibition||St. Jude Children's Research Hospital / Adam Durbin, PhD||Young Investigator Grants||2018||Tennessee|
|The Role of Pyruvate Dehydrogenase in Leukemia||University of Texas Southwestern Medical Center at Dallas / Michalis Agathocleous, PhD||'A' Award Grants||2018||Texas|
|Energy Balance Strategies for Decreasing Chemotherapy-Induced Cardiotoxicity||University of Texas M.D. Anderson Cancer Center / Eugenie Kleinerman, MD||Innovation Grants||2018||Texas|
|Modeling and Therapeutic Targeting of p21-Activated Kinase Members in High-Risk Rhabdomyosarcoma||Baylor College of Medicine / Jason Yustein, MD/PhD||Innovation Grants||2018||Texas|
|RNA Methylation in Metabolically Disrupted Pediatric Cancers||University of Texas Health Science Center at San Antonio / Patricia Dahia, MD/PhD||Innovation Grants||2018||Texas|